Lipid-Lowering Drugs Reversed Cognitive Decline: At 1 year, active therapy significantly improved patients' memory and speed of data processing.

VIENNA — Potent cholesterol-lowering therapy appears to reverse neurocognitive decline in normolipidemic elderly patients with atrial fibrillation, Dr. Elke Wezenberg said at the annual congress of the European Society of Cardiology.